3-Methoxycatechol
(Synonyms: 3-甲氧基儿茶酚) 目录号 : GC49874
A lignan-derived phenol
Cas No.:934-00-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
3-Methoxycatechol is a lignan-derived phenol.1 It is an agonist of G protein-coupled receptor 35 (GPR35) with an EC50 value of 147 µM in a dynamic mass redistribution (DMR) assay using HT-29 cells.2 Dietary administration of 3-methoxycatechol (2%) alone, or in a model of multiorgan carcinogenesis induced by nitrosamines, promotes esophageal carcinogenesis in rats.3 3-Methoxycatechol has been used as a precursor in the enzymatic synthesis of the phenols pyrogallol and purpurogallin and in the electro-organic synthesis of coumestan derivatives.1,4
1.Zhang, S., Xiaofeng, W., and Xiao, Y.Conversion of lignin-derived 3-methoxycatechol to the natural product purpurogallin using bacterial P450 GcoAB and laccase CueOAppl. Microbiol. Biotechnol.106(2)593-603(2022) 2.Deng, H., and Fang, Y.The three tatecholics benserazide, catechol and pyrogallol are GPR35 agonistsPharmaceuticals (Basel)6(4)500-509(2013) 3.Hirose, M., Tnaka, H., Takahashi, S., et al.Effects of sodium nitrite and catechol, 3-methoxycatechol, or butylated hydroxyanisole in combination in a rat multiorgan carcinogenesis modelCancer Res.53(1)32-37(1993) 4.Golabi, S.M., and Nematollahi, D.Electrochemical study of catechol and some 3-substituted catechols in the prescence of 4-hydroxy coumarin: Application to the electro-organic synthesis of new coumestan derivativesJ. Electroanal. Chem.420(1-2)127-134(1997)
| Cas No. | 934-00-9 | SDF | Download SDF |
| 别名 | 3-甲氧基儿茶酚 | ||
| Canonical SMILES | OC1=CC=CC(OC)=C1O | ||
| 分子式 | C7H8O3 | 分子量 | 140.1 |
| 溶解度 | DMF: 3 mg/ml,DMSO: 2 mg/ml,Ethanol: 2 mg/ml,PBS (pH 7.2): 2 mg/ml | 储存条件 | -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 7.1378 mL | 35.6888 mL | 71.3776 mL |
| 5 mM | 1.4276 mL | 7.1378 mL | 14.2755 mL |
| 10 mM | 0.7138 mL | 3.5689 mL | 7.1378 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet